Ibex Technologies specializes in the production of various heparinases, including Heparinase I, II, and III, which are crucial for diagnostic applications. Heparinase I, in particular, is designed to neutralize both unfractionated and low molecular weight heparin, facilitating the monitoring of baseline hemostasis in patients undergoing anticoagulant therapy. The company adheres to ISO 13485 standards in the production of its diagnostic products, ensuring high quality and reliability. Additionally, Ibex offers chondroitinase enzymes, which are also part of their product lineup, further expanding their capabilities in the field of glycosaminoglycan (GAG) enzymes.

In addition to their product offerings, Ibex Technologies provides contract manufacturing services for enzyme reagents, catering to some of the largest international diagnostic companies. Their services include custom fermentation, protein purification, and lyophilization, all performed under strict ISO 13485 guidelines. The company has developed a proprietary expression system using Flavobacterium heparinum to produce GAG enzymes with high purity, minimizing cross-contamination risks. This focus on quality and innovation positions Ibex as a key player in the biotechnology sector, particularly in enzyme production for research and diagnostic applications.

Canada

IBEX is a pharmaceutical company that specializes in manufacturing and selling high purity enzymes for in-vitro diagnostics and research, as well as osteoarthritis kits for pre-clinical research.

Ibex Technologies

Company Details